A study published in the New England Journal of Medicine has suggested semaglutide can improve knee pain in people with obesity and OA.

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study ...

Knee problems can hinder mobility and erode your quality of life.

Authors of a new 407-patient study, sponsored by Novo Nordisk, wrote that obese patients with knee osteoarthritis (OA) and ...

also known as degenerative joint disease of the knee, is the most common type of osteoarthritis, resulting in chronic pain and an impaired quality of life. Obesity is a major risk factor for the ...

Now, new research published on October 30, 2024, in The New England Journal of Medicine adds to the list, finding that ...

Here are four things to know about knee pain and GLP-1s based on studies and surgeon observations from 2024: ...

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

Obese knee arthritis sufferers experienced almost a 50% reduction in knee pain after taking Ozempic as part of a study published last month in the New England Journal of Medicine. “We know ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

About 25% of adults experience knee pain, according to a 2018 study published ... But sore knees may also result from an injury, weak or tight muscles, obesity, overuse, or muscle imbalances.

Study will track how adults 65 or older living with obesity respond to activity and nutrition coaching. Setting out to prove ...